Chronic nicotine treatment has shown protection from nAChR synaptic impairments believed to be induced by Aβ oligomers in rat models of Alzheimer's disease and prevention of impaired learning and short-term memory [11]. This evidence concerns the gene CHRNA4 and Alzheimer disease.